State of Wyoming - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
State of Wyoming ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
8
-99.3%
0.00%
-100.0%
Q1 2022$36,000
+100.0%
1,134
+193.8%
0.02%
+125.0%
Q4 2021$18,000
+350.0%
386
+451.4%
0.01%
+166.7%
Q3 2021$4,000
-84.6%
70
-79.2%
0.00%
-81.2%
Q2 2021$26,000
+62.5%
337
+21.7%
0.02%
-38.5%
Q1 2021$16,0002770.03%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders